{
    "nct_id": "NCT03465618",
    "official_title": "Imaging of Patients With Malignant Brain Tumors Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers: A Phase 1 Microdosing Study",
    "inclusion_criteria": "* 18 years of age or older\n* Histologically confirmed diagnosis of malignant primary brain tumor clinical and radiographic findings consistent with a pituitary adenoma, or known metastatic cancer with brain lesion presumed to be metastatic.\n* Normal baseline cardiac function based upon pre-operative evaluation at the physcian's discretion\n* All patients of childbearing age must use an acceptable form of birth control\n* Women who are pre-menopausal must have a negative serum pregnancy test\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Known pregnancy or breast-feeding Medical illness unrelated to the tumor which in the opinion of the attending physician and principal investigator will preclude administration of the tracer\n\n  Â°This includes patients with uncontrolled infection, chronic renal insufficiency, myocardial infarction within the past 6 months, unstable angina, cardiac arrhythmias other than chronic atrial fibrillation and chronic active or persistent hepatitis, or New York Heart Association Classification III or IV heart disease\n* More than one metastatic cancer active in the last 5 years\n* Active metastatic cancer in addition to malignant primary brain tumor\n* Weight greater than the 400-lb weight limit of the PET scanner\n* Unmanageable claustrophobia\n* Inability to lie in the scanner for 30 minutes",
    "miscellaneous_criteria": ""
}